Home > Share Market > Stocks > Kwality pharmaceuticals > Financial Statements > Key Financial Ratios

Kwality pharmaceuticals Financial Statements

Kwality pharmaceuticals Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 88.10 1.31 39.80 32.50
Op profit growth 103 21.70 32.10 76.70
EBIT growth 78.50 41.50 26 105
Net profit growth 82.10 82.90 35.10 116
Profitability ratios (%)        
OPM 11 10.20 8.48 8.98
EBIT margin 9.14 9.63 6.90 7.65
Net profit margin 5.78 5.97 3.31 3.42
RoCE 26.40 19.80 18.90 19
RoNW 7.07 5.49 4.11 3.55
RoA 4.18 3.07 2.27 2.12
Per share ratios ()        
EPS 14.40 7.91 4.26 6.32
Dividend per share -- -- -- 0.60
Cash EPS 8.34 3.74 1.51 1.65
Book value per share 58.90 44.30 28.70 49.30
Valuation ratios        
P/E 3.90 3.23 9.62 7.59
P/CEPS 6.72 6.83 27.10 29.10
P/B 0.95 0.58 1.43 0.97
EV/EBIDTA 3.07 3.36 5.41 6.57
Payout (%)        
Dividend payout -- -- -- 11
Tax payout (30) (25) (39) (42)
Liquidity ratios        
Debtor days 46 88.30 79.20 75.40
Inventory days 27.70 49.10 38.30 44.90
Creditor days (38) (66) (51) (46)
Leverage ratios        
Interest coverage (9) (5.40) (4.30) (4)
Net debt / equity 0.58 0.73 0.83 0.63
Net debt / op. profit 1.23 2.36 2.13 1.82
Cost breakup ()        
Material costs (63) (63) (74) (72)
Employee costs (6.10) (8.60) (4.10) (4.30)
Other costs (20) (19) (14) (14)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000